gatifloxacin has been researched along with Myopia in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Myopia: A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eyes treated with moxifloxacin healed faster and had smaller defects compared with those treated with gatifloxacin." | 2.71 | The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. ( Bower, KS; Burka, JM; Howard, RS; Kuzmowych, CP; Stutzman, RD; Vanroekel, RC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burka, JM | 1 |
| Bower, KS | 1 |
| Vanroekel, RC | 1 |
| Stutzman, RD | 1 |
| Kuzmowych, CP | 1 |
| Howard, RS | 1 |
| Moshirfar, M | 1 |
| Mirzaian, G | 1 |
| Feiz, V | 1 |
| Kang, PC | 1 |
| de la Cruz, J | 1 |
| Behlau, I | 1 |
| Pineda, R | 1 |
| Ursea, R | 1 |
| Purcell, TL | 1 |
| Tan, BU | 1 |
| Nalgirkar, A | 1 |
| Lovaton, ME | 1 |
| Ehrenhaus, MR | 1 |
| Schanzlin, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Clinical Trial Comparing the Effect of Moxifloxacin Versus Gatifloxacin Following Pterygium Excision on Corneal Epithelial Healing and Epithelial Toxicity.[NCT00892918] | 40 participants (Anticipated) | Interventional | 2009-06-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for gatifloxacin and Myopia
| Article | Year |
|---|---|
The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Astigmatism; Aza Compounds; Double-Blind Metho | 2005 |
3 other studies available for gatifloxacin and Myopia
| Article | Year |
|---|---|
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
Topics: Adult; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Com | 2006 |
Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
Topics: Adult; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; | 2007 |
The effect of cyclosporine A (Restasis) on recovery of visual acuity following LASIK.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Astigmatism; Cyclosporine; Drug Therapy | 2008 |